Improvement in Disability Assessment Scale after Botulinum toxin A treatment for upper limb spasticity

  • Fujimura Kenta
    Faculty of Rehabilitation, School of Health Sciences, Fujita Health University
  • Kagaya Hitoshi
    Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University
  • Onaka Hisae
    Department of Rehabilitation, Fujita Health University Hospital
  • Okochi Yuki
    Department of Rehabilitation, Fujita Health University Hospital
  • Yamada Masayuki
    Faculty of Rehabilitation, School of Health Sciences, Fujita Health University
  • Teranishi Toshio
    Faculty of Rehabilitation, School of Health Sciences, Fujita Health University
  • Kanada Yoshikiyo
    Faculty of Rehabilitation, School of Health Sciences, Fujita Health University
  • Saitoh Eiichi
    Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University

抄録

<p>Fujimura K, Kagaya H, Onaka H, Okochi Y, Yamada M, Teranishi T, Kanada Y, Saitoh E. Improvement in Disability Assessment Scale after Botulinum toxin A treatment for upper limb spasticity. Jpn J Compr Rehabil Sci 2017; 8: 4-9.<br>Objective: We investigated the effect of botulinum toxin type A for upper limb spasticity on activities of daily living using the Disability Assessment Scale (DAS).<br>Methods: The subjects were 47 patients who received botulinum therapy for upper limb spasticity. They were assessed before administration and 2, 6, and 12 weeks after administration by using the DAS, the Modified Ashworth Scale (MAS), and upper-limb-related parameters from the Fugl-Meyer Assessment (FMA).<br>Results: DAS scores for hygiene, dressing, and limb position improved significantly 2 and 6 weeks after administration (p < 0.05), but there was no significant change in pain. MAS scores exhibited significant improvement 2, 6, and 12 weeks after administration, and the total scores for FMA upper-limb parameters exhibited significant improvement 2 and 6 weeks after administration (p < 0.05).<br>Conclusion: Botulinum therapy contributes to improving not only the spasticity itself, but also to improving difficulties in activities of daily living associated with upper limb spasticity.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (26)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ